Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boards
Background and introduction: Growing evidence supports a combined modality treatment strategy for patients with oligometastatic disease. However, lack of phase III trial data and uncertainties around patient selection highlight the importance of multidisciplinary tumor boards (MDT) in therapeutic de...
Main Authors: | Sebastian M. Christ, Philip Heesen, Urs J. Muehlematter, Kaspar Pohl, Gabriel William Thiel, Jonas Willmann, Maiwand Ahmadsei, Tiuri E. Kroese, Michael Mayinger, Panagiotis Balermpas, Andreas Wicki, Nicolaus Andratschke, Martin Huellner, Matthias Guckenberger |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Clinical and Translational Radiation Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405630822001070 |
Similar Items
-
Patterns of metastatic spread and tumor burden in unselected cancer patients using PET imaging: Implications for the oligometastatic spectrum theory
by: Sebastian M. Christ, et al.
Published: (2024-03-01) -
Efficacy and safety analysis in metastatic cancer patients treated with multiple courses of repeat radiation therapy
by: Maiwand Ahmadsei, et al.
Published: (2023-11-01) -
Modern approach in oligometastatic prostate cancer therapy
by: Stanić Jelena, et al.
Published: (2023-01-01) -
Stereotactic radiotherapy or metastasectomy for oligometastatic esophagogastric cancer: A nationwide population-based cohort study
by: Tiuri E. Kroese, et al.
Published: (2022-11-01) -
Therapy of Locally Advanced and Oligometastatic Pancreatic Adenocarcinoma
by: Isabell Luisa Wahler, et al.
Published: (2023-12-01)